tradingkey.logo

Israel's InMode Q4 revenue up 6% but slightly misses estimates

ReutersFeb 10, 2026 12:10 PM


Overview

  • Israel medical tech firm's Q4 revenue slightly missed analyst expectations, EPS met estimates

  • Company's Q4 revenue grew 6% yr/yr to $103.9 mln

  • Returned $127.4 mln to shareholders through share repurchases in 2025


Outlook

  • InMode expects 2026 revenue between $365 mln and $375 mln

  • Company anticipates non-GAAP EPS between $1.43 and $1.48 for 2026

  • InMode plans to launch two new laser-based platforms in 2026


Result Drivers

  • EUROPEAN GROWTH - Record revenue in European operations contributed to Q4 growth, per CFO Yair Malca

  • NORTH AMERICA STABILIZATION - Co sees early signs of stabilization in North America despite ongoing challenges, per CEO Moshe Mizrahy

  • LEADERSHIP CHANGES - Refreshed sales and post-sales leadership teams in North America aim to enhance service capabilities, per President Michael Dennison


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Slight Miss*

$103.85 mln

$104.40 mln (8 Analysts)

Q4 EPS

Meet

$0.42

$0.42 (7 Analysts)

Q4 Net Income

Slight Miss*

$27.03 mln

$27.20 mln (5 Analysts)

Q4 Gross Margin

78.00%

Q4 Pretax Profit

Beat

$31.29 mln

$29.98 mln (6 Analysts)

Q4 Operating Expenses

$55.31 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

  • Wall Street's median 12-month price target for Inmode Ltd is $16.00, about 5.8% above its February 9 closing price of $15.12

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago

Press Release: ID:nPn8kfg7Ja

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI